申请人:——
公开号:US20020058701A1
公开(公告)日:2002-05-16
The use of isolated or purified stilbenoid compounds including longistyline A-2-carboxylic acid as hypoglycemic agents or to lower serum glucose levels is described. The invention also relates to the use of such stibenoid compounds in combination with other hypoglycemic agents.
本发明描述了分离或纯化的石杉碱类化合物(包括龙葵碱 A-2-羧酸)作为降血糖剂或降低血清葡萄糖水平的用途。本发明还涉及将这类石杉碱类化合物与其他降血糖药结合使用。